Terms: = Leukemia AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Prognosis
30 results:
1. [Real-world clinical data analysis of PARPi as first-line maintenance therapy in newly diagnosed epithelial ovarian cancer patients].
Wang DF; Zhang J; Zhang C; Yu J; Shi Y; Xu SQ; Fan Y; Zhou FZ; Song SQ; Liu H; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2022 Sep; 57(9):641-652. PubMed ID: 36177575
[No Abstract] [Full Text] [Related]
2. Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.
Baranwal A; Hahn CN; Shah MV; Hiwase DK
Curr Hematol Malig Rep; 2022 Dec; 17(6):254-265. PubMed ID: 35986863
[TBL] [Abstract] [Full Text] [Related]
3. Methylation of DNA Repair Genes as a Prognostic Biomarker in AML of a TCGA-LAML Cohort.
Park S; So MK; Huh J
Clin Lab; 2022 Jul; 68(7):. PubMed ID: 35975527
[TBL] [Abstract] [Full Text] [Related]
4. Pneumocystis jirovecii-associated immune reconstitution inflammatory syndrome-like phenomenon in a child with leukaemia: a case report and literature review.
Lei JY; Chen H; Zhou DH; Xu LH; Fang JP; Mai YG
BMC Pediatr; 2022 Jul; 22(1):410. PubMed ID: 35820900
[TBL] [Abstract] [Full Text] [Related]
5. Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature.
Denier M; Tick S; Dubois R; Dulery R; Eller AW; Suarez F; Burroni B; Maurage CA; Bories C; Konopacki J; Puech M; Bouscary D; Cantalloube A; Héron E; Marçais A; Habas C; Theillac V; Keilani C; Bonhomme GR; Gallagher DS; Boumendil J; Abarah W; Sedira N; Bertin S; Choquet S; Sahel JA; Merabet L; Brignole-Baudouin F; Putterman M; Errera MH
Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334633
[No Abstract] [Full Text] [Related]
6. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia.
Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J
Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078
[TBL] [Abstract] [Full Text] [Related]
7. Gene Expression Analysis of Pediatric Acute Myeloid leukemia Identified a Hyperactive ASXL1/BAP1 Axis Linked with Poor prognosis and over Expressed Epigenetic Modifiers.
Elyamany G; Akhter A; Kamran H; Rizwan H; Shabani-Rad MT; Alkhayat N; Al Sharif O; Elborai Y; Al Shahrani M; Mansoor A
Pediatr Hematol Oncol; 2021 Sep; 38(6):581-592. PubMed ID: 33764257
[TBL] [Abstract] [Full Text] [Related]
8. Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell Transplantation.
Takenaka K; Onishi Y; Mori T; Hirakawa T; Tada Y; Uchida N; Kobayashi T; Kanda Y; Ozawa Y; Ota S; Iida H; Fukushima K; Kimua T; Fukuda T; Atsuta Y; Matsuto K; Yamazaki H; Nakasone H
Transplant Cell Ther; 2021 Jan; 27(1):82.e1-82.e8. PubMed ID: 33039517
[TBL] [Abstract] [Full Text] [Related]
9. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.
Xia YK; Zeng YR; Zhang ML; Liu P; Liu F; Zhang H; He CX; Sun YP; Zhang JY; Zhang C; Song L; Ding C; Tang YJ; Yang Z; Yang C; Wang P; Guan KL; Xiong Y; Ye D
Protein Cell; 2021 Jul; 12(7):557-577. PubMed ID: 32683582
[TBL] [Abstract] [Full Text] [Related]
10. hCINAP regulates the DNA-damage response and mediates the resistance of acute myelocytic leukemia cells to therapy.
Xu R; Yu S; Zhu D; Huang X; Xu Y; Lao Y; Tian Y; Zhang J; Tang Z; Zhang Z; Yi J; Zhu HH; Zheng X
Nat Commun; 2019 Aug; 10(1):3812. PubMed ID: 31444354
[TBL] [Abstract] [Full Text] [Related]
11. A practical guide for mutational signature analysis in hematological malignancies.
Maura F; Degasperi A; Nadeu F; Leongamornlert D; Davies H; Moore L; Royo R; Ziccheddu B; Puente XS; Avet-Loiseau H; Campbell PJ; Nik-Zainal S; Campo E; Munshi N; Bolli N
Nat Commun; 2019 Jul; 10(1):2969. PubMed ID: 31278357
[TBL] [Abstract] [Full Text] [Related]
12. Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
Maifrede S; Nieborowska-Skorska M; Sullivan-Reed K; Dasgupta Y; Podszywalow-Bartnicka P; Le BV; Solecka M; Lian Z; Belyaeva EA; Nersesyan A; Machnicki MM; Toma M; Chatain N; Rydzanicz M; Zhao H; Jelinek J; Piwocka K; Sliwinski T; Stoklosa T; Ploski R; Fischer T; Sykes SM; Koschmieder S; Bullinger L; Valent P; Wasik MA; Huang J; Skorski T
Blood; 2018 Jul; 132(1):67-77. PubMed ID: 29784639
[TBL] [Abstract] [Full Text] [Related]
13. DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome.
Ribeiro HL; Maia ARS; de Oliveira RTG; Costa MB; Farias IR; de Paula Borges D; de Sousa JC; Magalhães SMM; Pinheiro RF
J Clin Pathol; 2017 Nov; 70(11):970-980. PubMed ID: 28554891
[TBL] [Abstract] [Full Text] [Related]
14. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid leukemia.
Hochhaus A; Larson RA; Guilhot F; Radich JP; Branford S; Hughes TP; Baccarani M; Deininger MW; Cervantes F; Fujihara S; Ortmann CE; Menssen HD; Kantarjian H; O'Brien SG; Druker BJ;
N Engl J Med; 2017 Mar; 376(10):917-927. PubMed ID: 28273028
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical and cytogenetic study of chromosome 1 abnormality in myelodysplastic syndrome].
Wang W; Chen Z; Yu M; Wang H; Lou J; Xu H; Hu C; Mu Q; Tong H; Wei J; Zhou X; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):818-23. PubMed ID: 26477758
[TBL] [Abstract] [Full Text] [Related]
16. UHRF1 promotes proliferation of gastric cancer via mediating tumor suppressor gene hypermethylation.
Zhou L; Shang Y; Jin Z; Zhang W; Lv C; Zhao X; Liu Y; Li N; Liang J
Cancer Biol Ther; 2015; 16(8):1241-51. PubMed ID: 26147747
[TBL] [Abstract] [Full Text] [Related]
17. BRCC3 mutations in myeloid neoplasms.
Huang D; Nagata Y; Grossmann V; Radivoyevitch T; Okuno Y; Nagae G; Hosono N; Schnittger S; Sanada M; Przychodzen B; Kon A; Polprasert C; Shen W; Clemente MJ; Phillips JG; Alpermann T; Yoshida K; Nadarajah N; Sekeres MA; Oakley K; Nguyen N; Shiraishi Y; Shiozawa Y; Chiba K; Tanaka H; Koeffler HP; Klein HU; Dugas M; Aburatani H; Miyano S; Haferlach C; Kern W; Haferlach T; Du Y; Ogawa S; Makishima H
Haematologica; 2015 Aug; 100(8):1051-7. PubMed ID: 26001790
[TBL] [Abstract] [Full Text] [Related]
18. Progressive multifocal leukoencephalopathy: Dot-shaped inclusions and virus-host interactions.
Shishido-Hara Y
Neuropathology; 2015 Oct; 35(5):487-96. PubMed ID: 25946231
[TBL] [Abstract] [Full Text] [Related]
19. prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline.
Branford S; Yeung DT; Parker WT; Roberts ND; Purins L; Braley JA; Altamura HK; Yeoman AL; Georgievski J; Jamison BA; Phillis S; Donaldson Z; Leong M; Fletcher L; Seymour JF; Grigg AP; Ross DM; Hughes TP
Blood; 2014 Jul; 124(4):511-8. PubMed ID: 24859364
[TBL] [Abstract] [Full Text] [Related]
20. Activating FLT3 mutants show distinct gain-of-function phenotypes in vitro and a characteristic signaling pathway profile associated with prognosis in acute myeloid leukemia.
Janke H; Pastore F; Schumacher D; Herold T; Hopfner KP; Schneider S; Berdel WE; Büchner T; Woermann BJ; Subklewe M; Bohlander SK; Hiddemann W; Spiekermann K; Polzer H
PLoS One; 2014; 9(3):e89560. PubMed ID: 24608088
[TBL] [Abstract] [Full Text] [Related]
[Next]